Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

NCT00547443 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Withdrawn as the sponsor has stopped the drug for NSCLC population

Conditions

Lung Cancer

Interventions

DRUG: carboplatin
DRUG: paclitaxel
DRUG: sorafenib tosylate
RADIATION: radiation therapy

Sponsor

University of Texas Southwestern Medical Center